Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Psioxus Therapeutics
1244
Psioxus Therapeutics
Health Care
Medical
Therapeutics
Immuno-oncology specialists with a clinical stage oncolytic virus program and the T-SIGn plaform for immuno-gene-therapy
Suggest edits
Founded
2010
Raised
$73.4M
Follow us
Featured on
Also headquartered in Oxford
Oxford University
Newton
Oxford Nanopore
Oxbotica
Latent Logic
Contego
Navenio
University of Oxford
Exscientia
PQShield
Companies in the same industry
Theranosis
reViral
Tvardi Therapeutics
Imcyse
Bold Health
Eureka Therapeutics
Monte Rosa Therapeutics
Tinnitracks
Immune Design
Adagene
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Latest funding
$39,241,539
Venture capital (Series C) - 2015
$34,118,753
Venture capital (Series B) - 2012
Team Size
10+
Employees
I work here
Location
Oxford
,
United Kingdom
Headquarters
Explore Oxford
No recent coverage
Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Psioxus Therapeutics makes some noise.
